You are here

Clinical Trials: Cord Blood

Conditions:   Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Acute Biphenotypic Leukemia;   Acute Lymphoblastic Leukemia in Remission;   Acute Myeloid Leukemia in Remission;   Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements;   ISS Stage II Plasma Cell Myeloma;   ISS Stage III Plasma Cell Myeloma;   Myelodysplastic Syndrome;   Recurrent Acute Lymphoblastic Leukemia;   Recurrent Acute Myeloid Leukemia;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Hodgkin Lymphoma;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Acute Lymphoblastic Leukemia;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hodgkin Lymphoma;   Refractory Non-Hodgkin Lymphoma;   Refractory Small Lymphocytic Lymphoma;   Secondary Acute Myeloid Leukemia;   Therapy-Related Acute Myeloid Leukemia;   Therapy-Related Myelodysplastic Syndrome
Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Fludarabine Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide;   Drug: Melphalan;   Drug: Mycophenolate Mofetil;   Biological: Natural Killer Cell Therapy;   Biological: Rituximab;   Drug: Tacrolimus;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Conditions:   Mucopolysaccharidosis I;   Mucopolysaccharidosis VI;   Adrenoleukodystrophy;   Niemann-Pick Disease;   Metachromatic Leukodystrophy;   Wolman Disease;   Krabbe's Disease;   Gaucher's Disease;   Fucosidosis;   Batten Disease;   Severe Aplastic Anemia;   Diamond-Blackfan Anemia;   Amegakaryocytic Thrombocytopenia;   Myelodysplastic Syndrome;   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia
Intervention:   Drug: Human Placental Derived Stem Cell
Sponsor:   New York Medical College
Active, not recruiting
Condition:   Sickle Cell Disease & Thalassemia
Intervention:   Drug: NiCord
Sponsor:   Gamida Cell ltd
Recruiting - verified May 2017
Conditions:   Leukemia;   Lymphoma
Interventions:   Drug: Rituximab;   Drug: 111In Ibritumomab;   Procedure: Planar Scintigraphy Imaging;   Drug: 90Y IbritumomabTiuxetan;   Drug: Fludarabine;   Drug: Bendamustine;   Drug: Thymoglobulin;   Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Mycophenolate;   Drug: G-CSF;   Procedure: Stem Cell Transplantation
Sponsors:   M.D. Anderson Cancer Center;   Spectrum Pharmaceuticals, Inc
Active, not recruiting - verified April 2017
Condition:   Hematologic Malignancies
Intervention:   Biological: StemEx
Sponsors:   Loyola University;   Gamida Cell ltd
Active, not recruiting
Conditions:   Acute Myelocytic Leukemia;   Acute Lymphocytic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndrome;   Chronic Lymphocytic Leukemia;   Marginal Zone Lymphoma;   Follicular Lymphomas;   Large-cell Lymphoma;   Lymphoblastic Lymphoma;   Burkitt's Lymphoma;   High Grade Lymphomas;   Mantle-cell Lymphoma;   Lymphoplasmacytic Lymphoma
Intervention:   Biological: HSC835
Sponsor:   Novartis Pharmaceuticals
Conditions:   Blood And Marrow Transplantation;   Leukemia;   Lymphoma;   Transplantation Infection;   Transplantation, Bone Marrow
Interventions:   Drug: Melphalan;   Drug: Fludarabine;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Procedure: Cord Blood Infusion;   Drug: Rituximab;   Drug: ATG;   Drug: Busulfan;   Drug: Clofarabine;   Radiation: Total Body Irradiation (TBI)
Sponsors:   M.D. Anderson Cancer Center;   American Stem Cell, Inc.;   National Cancer Institute (NCI)
Completed - verified April 2017
Condition:   Chronic Lymphocytic Leukemia
Intervention:   Drug: Allogeneic Cell Therapy w/ Tumor-derived Lypho
Sponsor:   National Cancer Institute (NCI)
Completed - verified April 24, 2013
Condition:   Chronic Graft-versus-host Disease
Intervention:   Drug: Interleukin-2
Sponsors:   Dana-Farber Cancer Institute;   National Cancer Institute (NCI);   Prometheus Laboratories
Active, not recruiting
Conditions:   Leukemia;   Lymphoma
Interventions:   Genetic: T-Cell Infusion;   Procedure: Cord Blood Infusion
Sponsor:   M.D. Anderson Cancer Center
Active, not recruiting - verified July 2017